tiprankstipranks
Argent Biopharma (RGTLF)
OTHER OTC:RGTLF

Argent Biopharma (RGTLF) Technical Analysis

28 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
6Bearish
Argent Biopharma’s (RGTLF) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Argent Biopharma is a Sell.
Argent Biopharma’s (RGTLF) 20-Day exponential moving average is 0.21, while Argent Biopharma’s (RGTLF) share price is $0.213, making it a Sell.
Argent Biopharma’s (RGTLF) 50-Day exponential moving average is 0.23, while Argent Biopharma’s (RGTLF) share price is $0.213, making it a Sell.

Argent Biopharma (RGTLF) Pivot Points

Jul 03, 2024, 09:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.13
0.15
0.18
0.20
0.23
0.25
0.28
Fibonacci
0.15
0.17
0.18
0.20
0.22
0.23
0.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Argent Biopharma (RGTLF) Moving Averages

Jul 03, 2024, 09:20 AM
Period
Simple
Exponential
MA5
0.19Buy
0.20Buy
MA10
0.20Buy
0.20Buy
MA20
0.20Sell
0.21Sell
MA50
0.24Sell
0.23Sell
MA100
0.26Sell
0.26Sell
Argent Biopharma’s (RGTLF) 10-Day exponential moving average is 0.20, while Argent Biopharma’s (RGTLF) share price is $0.213, making it a Buy.
Argent Biopharma’s (RGTLF) 100-Day exponential moving average is 0.26, while Argent Biopharma’s (RGTLF) share price is $0.213, making it a Sell.
Argent Biopharma’s (RGTLF) stock price is $0.213 and Argent Biopharma’s (RGTLF) 50-day simple moving average is 0.24, creating a Sell signal.
Argent Biopharma’s (RGTLF) stock price is $0.213 and Argent Biopharma’s (RGTLF) 100-day simple moving average is 0.26, creating a Sell signal.

Argent Biopharma (RGTLF) Technical Indicators

Jul 03, 2024, 09:20 AM
Name
Value
Implied Action
RSI (14)
44.30
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
66.67
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
8.43
Buy
Williams %R
-33.33
Buy
CCI (14)
-21.14
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
47.60
Neutral
ROC
-4.76
Sell
Argent Biopharma’s (RGTLF) Relative Strength Index (RSI) is 44.30, creating a Neutral signal.
Argent Biopharma’s (RGTLF) Trend Strength Indicator (ADX) is 8.43, creating a Buy signal.
Argent Biopharma’s (RGTLF) Commodity Channel Index (CCI) is -21.14, creating a Neutral signal.
Argent Biopharma’s (RGTLF) Price Rate of Change (ROC) is -4.76, creating a Sell signal.

FAQ

Is RGTLF a Buy, Hold, or Sell?
Based on RGTLF’s technical indicators, RGTLF is a Sell.
    What is RGTLF’s RSI (14)?
    RGTLF’s RSI (14) is 44.30, which suggests RGTLF is a Neutral.
      What is RGTLF’s MACD?
      RGTLF’s MACD is -0.01, which suggests RGTLF is a Sell.
        What is RGTLF’s 5-day moving average?
        RGTLF’s 5-day moving average is 0.19, which suggests RGTLF is a Buy.
          What is RGTLF’s 20-day moving average?
          RGTLF 20-day moving average is 0.20, which suggests RGTLF is a Sell.
            What is RGTLF’s 50-day moving average?
            RGTLF’s 50-day moving average is 0.24, which suggests RGTLF is a Sell.
              What is RGTLF’s 200-day moving average?
              Currently, no data Available
              What is RGTLF’s Williams % R (14)?
              RGTLF’s Williams % R (14) is -33.33, which suggests RGTLF is a Buy.
                What is RGTLF’s CCI (14)?
                RGTLF’s CCI (14) is -21.14, which suggests RGTLF is a Neutral.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis